NYSE$NVST

Envista Holdings Corporation · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

Envista's sales increased and net income was reported for the fourth quarter and fiscal year 2021.

Envista Holdings Corporation reported a 5.8% increase in sales to $651.8 million for the fourth quarter ended December 31, 2021, with core sales growth of 6.6%. Net income for the quarter was $42.5 million, or $0.24 per diluted share, while adjusted earnings per diluted share was $0.46. The company expects to deliver core growth of between 6-8% and deliver a full year adjusted EBITDA margin of >20% for 2022.

  • Sales increased 5.8% to $651.8 million.
  • Core sales growth was 6.6%.
  • Net income was $42.5 million, or $0.24 per diluted share.
  • Adjusted earnings per diluted share was $0.46.

Headline financials

Total Revenue

$652M

Previous: $732M-11.0%
EPS (adj)

$0.46

Previous: $0.56-17.9%
Total Core Sales Growth

6.6%

Previous: 3.4%+94.1%
Capital Expenditures

$8.7M

Previous: $13.1M-33.6%
Free Cash Flow

$127M

Previous: $186M-31.4%
Net Income

$42.5M

Previous: $108M-60.8%
Operating Income

$46.1M

Previous: $96.8M-52.4%
Gross Profit

$343M

Previous: $389M-11.7%
Cash & Equivalents

$1.07B

Previous: $889M+20.8%
Total Assets

$6.57B

Previous: $6.88B-4.4%
Stock-Based Comp

$6.6M

Previous: $22.6M-70.8%

Revenue & EPS history

Envista · Revenue · Quarterly

$652M

Q4 2021-11%vs Q4 2020
Beat estimate in 11 of 13 quarters(85%)
ActualEstimate

Revenue by segment

Envista · $652M total across 2 segments · Q4 2021

  • Specialty Products & Technologies
    $392M+14.1%
  • Equipment & Consumables
    $260M-33.2%

Forward guidance

For 2022, barring any significant COVID related disruptions, the company expects to deliver core growth of between 6-8% and deliver a full year adjusted EBITDA margin of >20%.

Tailwinds

  • Expect to deliver core growth of between 6-8%.
  • Deliver a full year adjusted EBITDA margin of >20%.
  • Focused on the faster growing, most attractive segments of the dental industry.
  • Actively partnering with Dental Service Organizations as they improve access to oral care.
  • Long-term positioned as the partner of choice for this fast-growing customer segment.

Headwinds

  • Guidance does not reflect the impact of the pending acquisition of Carestream Dental’s IOS business.
  • Significant COVID related disruptions
  • Global supply chain disruptions
  • Potential staffing shortages
  • Impact of debt obligations on operations and liquidity

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

-0.1%

Avg return

Earnings day

+1.6%

Avg return

5 days after

-0.8%

Avg return

30 days after

48%

16 / 33 earnings

Positive

+17.8%

Q4 2025

Best reaction

-9.7%

Q1 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+1.5%-10.3%-14.7%
Q4 2025+17.8%+22.5%+8.7%
Q3 2025-0.2%+0.0%+3.8%
Q1 2025+3.8%+3.1%+11.8%
Q4 2024+5.9%+2.2%-10.4%
Q3 2024+11.6%+13.3%+18.6%
Q2 2024+4.7%+2.9%+10.7%
Q1 2024+0.7%-3.2%-1.6%
Q4 2023-8.5%-7.0%-13.4%
Q3 2023-8.7%-8.3%+2.7%
Q2 2023+0.8%+2.8%-4.8%
Q1 2023-6.4%-7.1%-12.0%
Q4 2022-3.0%-3.5%-9.8%
Q3 2022+2.8%+3.4%+4.0%
Q2 2022+1.3%+1.4%-11.3%
Q1 2022+7.5%+5.4%+6.2%
Q4 2021+8.7%+8.0%+3.9%
Q3 2021+5.4%+6.1%-3.9%
Q2 2021-7.5%-6.1%+0.3%
Q1 2021+2.1%+3.1%-4.1%
Q4 2020+2.2%+3.6%+4.7%
Q3 2020+7.8%+9.9%+20.4%
Q2 2020-3.8%+0.4%+5.2%
Q1 2019-9.7%-8.9%+10.7%
Q1 2020-9.7%-8.9%+10.7%
Q4 2019-6.5%-8.1%-19.8%
Q4 2018-3.2%+5.3%-5.9%
Q4 2017-3.2%+5.3%-5.9%
Q3 2018-3.2%+5.3%-5.9%
Q3 2019-3.2%+5.3%-5.9%
Q2 2019-3.2%+5.3%-5.9%
Q2 2018-3.2%+5.3%-5.9%
Q1 2018-3.2%+5.3%-5.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro